These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 10933516

  • 1. Application of chrome azurol S for the extractive spectrophotometric determination of fluoxetine and fluvoxamine.
    Starczewska B, Mielech K.
    J Pharm Biomed Anal; 2000 Aug 15; 23(2-3):243-7. PubMed ID: 10933516
    [Abstract] [Full Text] [Related]

  • 2. Investigation and analytical application of the reactions of eriochrome cyanine R with fluvoxamine and fluoxetine.
    Starczewska B, Puzanowska-Tarasiewicz H, Baranowska K.
    J Pharm Biomed Anal; 2000 Aug 15; 23(2-3):477-81. PubMed ID: 10933541
    [Abstract] [Full Text] [Related]

  • 3. Study and analytical application of ion-pair formation in the system fluoxetine-pyrocatechol violet and fluvoxamine-pyrocatechol violet.
    Starczewska B, Jasińska A, Białous B.
    Pharmazie; 2003 Apr 15; 58(4):245-8. PubMed ID: 12749405
    [Abstract] [Full Text] [Related]

  • 4. Determination of fluoxetine, fluvoxamine, and clomipramine in pharmaceutical formulations by capillary gas chromatography.
    Berzas Nevado JJ, Villaseñor Llerena MJ, Contento Salcedo AM, Aguas Nuevo E.
    J Chromatogr Sci; 2000 May 15; 38(5):200-6. PubMed ID: 10813517
    [Abstract] [Full Text] [Related]

  • 5. Determination of four selective serotonin reuptake inhibitors by capillary isotachophoresis.
    Buzinkaiová T, Polonský J.
    Electrophoresis; 2000 Aug 15; 21(14):2839-41. PubMed ID: 11001291
    [Abstract] [Full Text] [Related]

  • 6. Studies and analytical application of reaction of imipramine with chrome azurol S.
    Starczewska B, Hałaburda P, Kojło A.
    J Pharm Biomed Anal; 2002 Oct 15; 30(3):553-60. PubMed ID: 12367680
    [Abstract] [Full Text] [Related]

  • 7. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
    Strauss WL, Unis AS, Cowan C, Dawson G, Dager SR.
    Am J Psychiatry; 2002 May 15; 159(5):755-60. PubMed ID: 11986128
    [Abstract] [Full Text] [Related]

  • 8. Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors.
    Johnson DJ, Sanderson H, Brain RA, Wilson CJ, Bestari KJ, Solomon KR.
    Regul Toxicol Pharmacol; 2005 Aug 15; 42(3):313-23. PubMed ID: 16024151
    [Abstract] [Full Text] [Related]

  • 9. Electroanalytical study of fluvoxamine.
    Nouws HP, Delerue-Matos C, Barros AA, Rodrigues JA, Santos-Silva A.
    Anal Bioanal Chem; 2005 Aug 15; 382(7):1662-8. PubMed ID: 15983767
    [Abstract] [Full Text] [Related]

  • 10. Spectrophotometric studies and application of imipramine-eriochrome cyanine R system for determination of imipramine in pharmaceuticals.
    Starczewska B.
    J Pharm Biomed Anal; 2000 Aug 15; 23(2-3):383-6. PubMed ID: 10933530
    [Abstract] [Full Text] [Related]

  • 11. Development and Validation of Green and High-Throughput Microwell Spectrophotometric Assay for the Determination of Selective Serotonin Reuptake Inhibitors in Their Pharmaceutical Dosage Forms.
    Darwish IA, Alzoman NZ.
    Molecules; 2023 May 21; 28(10):. PubMed ID: 37241961
    [Abstract] [Full Text] [Related]

  • 12. [The transfer of selective serotonin reuptake inhibitors to human milk].
    Nordeng H, Bergsholm YK, Bøhler E, Spigset O.
    Tidsskr Nor Laegeforen; 2001 Jan 20; 121(2):199-203. PubMed ID: 11475200
    [Abstract] [Full Text] [Related]

  • 13. Development and validation of spectrophotometric methods for determination of fluoxetine, sertraline, and paroxetine in pharmaceutical dosage forms.
    Darwish IA.
    J AOAC Int; 2005 Jan 20; 88(1):38-45. PubMed ID: 15759724
    [Abstract] [Full Text] [Related]

  • 14. Spectrophotometric determination of fluoxetine hydrochloride in bulk and in pharmaceutical formulations.
    Prabhakar AH, Patel VB, Giridhar R.
    J Pharm Biomed Anal; 1999 Jul 20; 20(3):427-32. PubMed ID: 10701958
    [Abstract] [Full Text] [Related]

  • 15. Stability of fluoxetine in stored plasma, aqueous, and methanolic solutions determined by HPLC with UV detection.
    Binsumait IA, Hadidi KA, Raghib SA.
    Pharmazie; 2001 Apr 20; 56(4):311-3. PubMed ID: 11338670
    [Abstract] [Full Text] [Related]

  • 16. [Methods of determination of fluoxetine nad fluvoxamine].
    Starczewska B, Mielech K, Kleszczewska E.
    Psychiatr Pol; 2002 Apr 20; 36(4):603-16. PubMed ID: 12298189
    [Abstract] [Full Text] [Related]

  • 17. Spectrofluorometric determination of fluvoxamine in dosage forms, spiked plasma, and real human plasma by derivatization with fluorescamine.
    El-Enany N.
    J AOAC Int; 2007 Apr 20; 90(2):376-83. PubMed ID: 17474508
    [Abstract] [Full Text] [Related]

  • 18. Extractive-spectrophotometric determination of some phenothiazines with dipicrylamine and picric acid.
    Regulska E, Tarasiewicz M, Puzanowska-Tarasiewicz H.
    J Pharm Biomed Anal; 2002 Jan 01; 27(1-2):335-40. PubMed ID: 11682241
    [Abstract] [Full Text] [Related]

  • 19. Photooxidation of the antidepressant drug Fluoxetine (Prozac®) in aqueous media by hybrid catalytic/ozonation processes.
    Méndez-Arriaga F, Otsu T, Oyama T, Gimenez J, Esplugas S, Hidaka H, Serpone N.
    Water Res; 2011 Apr 01; 45(9):2782-94. PubMed ID: 21458837
    [Abstract] [Full Text] [Related]

  • 20. Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms.
    Yamada J, Sugimoto Y, Inoue K.
    Eur J Pharmacol; 1999 Oct 15; 382(3):211-5. PubMed ID: 10556672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.